CN104513211B - A kind of method preparing linezolid - Google Patents

A kind of method preparing linezolid Download PDF

Info

Publication number
CN104513211B
CN104513211B CN201310453588.1A CN201310453588A CN104513211B CN 104513211 B CN104513211 B CN 104513211B CN 201310453588 A CN201310453588 A CN 201310453588A CN 104513211 B CN104513211 B CN 104513211B
Authority
CN
China
Prior art keywords
inorganic base
catalyst
linezolid
alumina load
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310453588.1A
Other languages
Chinese (zh)
Other versions
CN104513211A (en
Inventor
陈国平
夏方方
杜成铭
陈丽庆
王霞
张梁
吴涛英
荆吉仁
夏新开
王海大
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DANYANG HENG'AN CHEMICAL TECHNOLOGY INSTITUTE Co Ltd
Original Assignee
DANYANG HENG'AN CHEMICAL TECHNOLOGY INSTITUTE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DANYANG HENG'AN CHEMICAL TECHNOLOGY INSTITUTE Co Ltd filed Critical DANYANG HENG'AN CHEMICAL TECHNOLOGY INSTITUTE Co Ltd
Priority to CN201310453588.1A priority Critical patent/CN104513211B/en
Publication of CN104513211A publication Critical patent/CN104513211A/en
Application granted granted Critical
Publication of CN104513211B publication Critical patent/CN104513211B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2

Abstract

The invention discloses a kind of method preparing linezolid.N { 2(R) 2 [(3 fluorine 4 morpholine 4 base phenyl) amino] 2 hydroxyethyls } acetamide and carbonylation agent are dissolved in organic solvent, add the inorganic base catalyst of alumina load, the pH value of control reaction system, in 8 10, reacts at 20 60 DEG C;Extract after cooling, wash, be dried, obtain linezolid solid after purification, recrystallization.Compared with prior art, the inorganic base that present invention employs alumina load is catalyst, replaces organic alkali catalyst, not only increases the atom utilization of reaction, and improve spatter property and the safety of industrially prepared reaction, reduce environmental pollution.Present invention employs the inorganic base of alumina load simple as catalyst preparation and can regenerate use and inventive process avoids and use high poison in prior synthesizing method, easily system poison reagent, improves the spatter property of commercial synthesis reaction, reduces environmental pollution.

Description

A kind of method preparing linezolid
Technical field
The present invention relates to the preparation method of a kind of (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides antibiotic, the synthetic method of a kind of linezolid, belong to medical chemistry synthesis field.
Background technology
In recent years, all kinds of antibiotic quickly grow with the fastbacteria of antimicrobial drug, such as, Methicillin resistant Staph. aureus (MRSA), Methicillin-resistant Staphylococcus epidermidis (MRSE), penicillin resistance pneumococcus (PRSP), multi-drug resistant tubercule bacillus, the most resistance to ten thousand appearance accounting for mycin enterococcus (VRE), difficulty is caused to clinical treatment, after antibacterial contact antibacterials, morphed by plasmid or Chromosome-encoded, obtain drug resistance, existing medicine is still difficult effectively controls these drug-fast bacteria infections, Pharmaceutical Chemist is promoted to make great efforts development of new anti-drug resistance bacterial drug, planned well screening has new chemical constitution, novel mechanism or the novel antibacterials of new role target position.
Linezolid, have another name called Linezolid, Lei Naizuoli, molecular formula is C16H20FN3O4, CAS:165800-03-3, chemical name: (S)-N-[[3-(3-fluoro-4-morpholino phenyl)-2-oxo-5-oxazolidinyl] methyl] acetamide, has lower formula (I) structure.Linezolid is the (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides antibiotic of synthetic, within 2000, obtains U.S. FDA approval, is used for treating Grain-positive (G+) coccigenic infection.
Substantially following three routes of the synthetic method of linezolid at present:
1. with 3,4 one difluoro nitrobenzenes are raw material, are substituted, reduce, are acylated, are condensed, are esterified, replace, ammonolysis and acetylization reaction synthesis linezolid.
2. using N-benzyloxycarbonyl group-3-fluoro-4-morpholinyl phenylamine to shrink at tert-butyl lithium ,-78 DEG C and R-Glycidyl Butyrate, obtain 5-hydroxymethyl oxazolidone, then diazotising, then hydrogenate, acetylization reaction obtains linezolid.
3. by fluoro-for 3-4-morpholinyl phenylamine and N-2(R)-epoxy acetamide is dissolved in organic solvent, react 10-30 hour at 20-100 DEG C, obtain N-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } acetamide, again the compound obtained and carbonylation agent are dissolved in halohydrocarbon organic solvent, under base catalyst is catalyzed, react 0.5-5 hour in 0-50 DEG C, obtain linezolid.
Although the third technique processing step is simple, reaction condition is gentle, but owing to using organic base or inorganic base catalyst, affects bigger on the yield of target product so that the productivity of whole technique is the highest.
Summary of the invention
The problem that it is an object of the invention to overcome prior art to exist, it is provided that a kind of method preparing linezolid.
Technical scheme is as follows: a kind of method preparing linezolid, comprises the steps:
The first step, by N-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } acetamide and carbonylation agent be dissolved in organic solvent, adding the inorganic base catalyst of alumina load, the pH value of control reaction system, in 8-10, reacts at 20-60 DEG C;
Second step, reaction extracts, washs, is dried after terminating, acquisition linezolid solid after purification, recrystallization.
Carbonylation agent described in the first step is methylchloroformate.
Organic solvent described in the first step is dichloromethane.
In the inorganic base catalyst of the alumina load described in the first step, inorganic base is sodium hydroxide or potassium hydroxide;The inorganic base catalyst of described alumina load and described N-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } acetamide mass ratio is 0.1-0.3.
Extraction described in second step uses ethyl acetate, described washing to use saturated sodium bicarbonate solution, described purification to use column chromatography;Described recrystallization uses ethyl acetate-light petrol.
Compared with prior art, the inorganic base that present invention employs alumina load is catalyst, replaces organic alkali catalyst, not only increases the atom utilization of reaction, and improve spatter property and the safety of industrially prepared reaction, reduce environmental pollution.Present invention employs the inorganic base of alumina load simple as catalyst preparation and can regenerate use and inventive process avoids and use high poison in prior synthesizing method, easily system poison reagent, improves the spatter property of commercial synthesis reaction, reduces environmental pollution.
Detailed description of the invention
Embodiment 1
By 50gN-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } sodium hydroxide catalyst of acetamide and 5g alumina load joins in 250ml dichloromethane, at 20-30 DEG C after magnetic agitation 0.5h, add 24g methylchloroformate, regulation system pH value be alkalescence (8-10) and continue magnetic agitation reaction 2h after, mixture glass funnel filters, and filters off catalyst.Filtrate is adopted and is extracted with ethyl acetate, and washs with water and saturated sodium bicarbonate, and anhydrous magnesium sulfate is dried, obtain target product linezolid 42.6g after rotary evaporation of solvent, column chromatography purification, ethyl acetate-light petrol recrystallization, and productivity is 84.7.
Embodiment 2
By 50gN-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } potassium hydroxide catalyst of acetamide and 15g alumina load joins in 250ml dichloromethane, at 30-40 DEG C after magnetic agitation 0.5h, add 24g methylchloroformate, regulation system pH value be alkalescence (8-10) and continue magnetic agitation reaction 2h after, mixture glass funnel filters, and filters off catalyst.Filtrate is adopted and is extracted with ethyl acetate, and washs with water and saturated sodium bicarbonate, and anhydrous magnesium sulfate is dried, obtain target product linezolid 43.2g after rotary evaporation of solvent, column chromatography purification, ethyl acetate-light petrol recrystallization, and productivity is 84.9.
Embodiment 3
By 50gN-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } sodium hydroxide catalyst of acetamide and 10g alumina load joins in 250ml dichloromethane, at 50-60 DEG C after magnetic agitation 0.5h, add 24g methylchloroformate, regulation system pH value be alkalescence (8-10) and continue magnetic agitation reaction 2h after, mixture glass funnel filters, and filters off catalyst.Filtrate is adopted and is extracted with ethyl acetate, and washs with water and saturated sodium bicarbonate, and anhydrous magnesium sulfate is dried, obtain target product linezolid 45.3g after rotary evaporation of solvent, column chromatography purification, ethyl acetate-light petrol recrystallization, and productivity is 86.1.

Claims (1)

1. the method preparing linezolid, it is characterised in that comprise the steps:
The first step, by N-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } acetamide and carbonylation agent be dissolved in organic solvent, adding the inorganic base catalyst of alumina load, the pH value of control reaction system, in 8-10, reacts at 20-60 DEG C;
Second step, reaction extracts, washs, is dried after terminating, acquisition linezolid solid after purification, recrystallization;
Wherein: the carbonylation agent described in the first step is methylchloroformate;
Organic solvent described in the first step is dichloromethane;
In the inorganic base catalyst of the alumina load described in the first step, inorganic base is sodium hydroxide or potassium hydroxide;The inorganic base catalyst of described alumina load and described N-{2(R)-2-[(the fluoro-4 morpholine-4-base phenyl of 3-) amino]-2-hydroxyethyl } acetamide mass ratio is 0.1-0.3;
Extraction described in second step uses ethyl acetate, described washing to use saturated sodium bicarbonate solution, described purification to use column chromatography;Described recrystallization uses ethyl acetate-light petrol.
CN201310453588.1A 2013-09-29 2013-09-29 A kind of method preparing linezolid Active CN104513211B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310453588.1A CN104513211B (en) 2013-09-29 2013-09-29 A kind of method preparing linezolid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310453588.1A CN104513211B (en) 2013-09-29 2013-09-29 A kind of method preparing linezolid

Publications (2)

Publication Number Publication Date
CN104513211A CN104513211A (en) 2015-04-15
CN104513211B true CN104513211B (en) 2017-01-04

Family

ID=52789115

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310453588.1A Active CN104513211B (en) 2013-09-29 2013-09-29 A kind of method preparing linezolid

Country Status (1)

Country Link
CN (1) CN104513211B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101220001A (en) * 2008-01-25 2008-07-16 浙江博泰化工有限公司 Synthesis of linezolid
CN102516191A (en) * 2011-12-21 2012-06-27 吉林省博大伟业制药有限公司 Method for preparing Linezolid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101220001A (en) * 2008-01-25 2008-07-16 浙江博泰化工有限公司 Synthesis of linezolid
CN102516191A (en) * 2011-12-21 2012-06-27 吉林省博大伟业制药有限公司 Method for preparing Linezolid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A new and alternate synthesis of Linezolid: An antibacterial agent;K.Chandra Babu 等;《Der Pharma Chemica》;20111231;第3卷(第4期);第219-226页 *

Also Published As

Publication number Publication date
CN104513211A (en) 2015-04-15

Similar Documents

Publication Publication Date Title
CN103755722B (en) The synthetic method of a kind of Levofloxacin and Ofloxacine USP 23
CN107325093B (en) Synthesis and application of thiourea compound with antibacterial activity
CN104513211B (en) A kind of method preparing linezolid
CN103113430B (en) Method for preparing etimicin sulfate
CN102516191A (en) Method for preparing Linezolid
CN105315231A (en) Preparation method of linezolid related substance
CN108084161A (en) The preparation method of De Lasha stars and its intermediate
CN111559985A (en) Oxazolone compound with bactericidal effect and preparation method thereof
CN109400607B (en) Abamebactam intermediate and preparation method thereof
CN105859747A (en) Cefepime dihydrochloride preparation method suitable for industrial production
US8871927B2 (en) Method for purifying Ceftizoxime sodium
CN103193692A (en) Preparation of valnemulin and hydrochloride of valnemulin
CN105198904A (en) Preparing method for levofloxacin and ofloxacin
CN112321580B (en) Oxazole linked triazole medicine molecule for sterilization and disinfection and preparation method and application thereof
CN105273045A (en) Synthesis and separation identification method for aragatroban related substances
CN104530082A (en) Cefathiamidine compound
CN105111160B (en) Linezolid preparation method
EP2816039A1 (en) Method for preparing linezolid intermediate
CN114031607A (en) Refining method of delafloxacin and intermediate thereof
CN104910090B (en) Dihydro-isoxazole class compound and its synthetic method
CN107778293A (en) A kind of preparation method of improved De Lasha stars
CN108640912A (en) A kind of industrially scalable preparation method of Pidotimod
CN111004255A (en) Preparation method of cefcapene lactone compound or hydrochloride thereof
CN113929684B (en) Meropenem intermediate and preparation method thereof
CN104844671A (en) 11-O-aromatic aralkyl carbamate clarithromycin derivatives as well as preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant